Novo Nordisk N1VO34 Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Entrate totali	48,09B	53,37B	54,3B	58,73B	65,86B	65,35B	68,06B	71,31B
Reddito operativo	17,09B	25,01B	23,89B	26,91B	26,85B	31,85B	25,93B	33,82B
Reddito ante imposte	16,32B	24,74B	24,25B	28,06B	27,62B	31,92B	25,33B	34,38B
Reddito netto	13,59B	19,81B	19,43B	22,48B	21,96B	25,41B	20,05B	27,3B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	17,09B	25,01B	23,89B	26,91B	26,85B	31,85B	25,93B	33,82B
EBITDA	19,12B	26,73B	26,07B	29,44B	29,84B	34,76B	34,78B	35,97B

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)	DKK (kr)
Entrate totali	111,78B	111,7B	111,83B	122,02B	126,95B	140,8B	176,95B	232,26B
Reddito operativo	48,46B	48,98B	47,26B	52,35B	54,28B	58,62B	74,62B	102,66B
Reddito ante imposte	47,8B	48,68B	47,62B	48,55B	53,13B	59,08B	69,06B	104,67B
Reddito netto	37,93B	37,28B	38,63B	38,95B	42,14B	47,76B	55,53B	83,68B
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	37.181	37.28	40.238	40.574	8.966	10.337	12.177	2.095
UTILE OPERATIVO	48,46B	48,98B	47,26B	52,35B	54,28B	58,62B	74,62B	102,66B
EBITDA	51,65B	52,16B	51,19B	58,01B	60,03B	64,65B	81,98B	112,07B